Active Ingredient(s): Ubrogepant
FDA Approved: * December 23, 2019
Pharm Company: * ALLERGAN
Category: Migraine / Tension Headache

Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults.[1][2] It is not indicated for the preventive treatment of migraine.[3] Ubrogepant is a small-molecule calcitonin gene-related peptide receptor antagonist.[4][5] It is the first drug in this class approved for the acute treat... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ubrelvy 50 mg Oral Tablet
NDC: 0023-6498
Allergan, Inc.
Ubrelvy 100 mg Oral Tablet
NDC: 0023-6501
Allergan, Inc.